BioAmber appoints Francois Laurin as CFO

BioAmber Inc, an industrial biotechnology company producing sustainable chemicals, has appointed Francois Laurin as the Chief Financial Officer in place of Andrew Ashworth, who retired on December 31, 2014.
 
Prior to BioAmber, Laurin was the CFO of Alderon Iron Ore Corp, a publicly listed exploration and development stage company in the mining sector. Laurin was formerly the CFO of Consolidated Thompson Iron Mines, where he played a leading role in the rapid growth of the company and its subsequent sale to Cliffs National Resources for $4.9 billion and prior to that he was the CFO of Transat AT. Laurin has also held senior financial positions at Caisse de Depot du Quebec, Bombardier and Teleglobe.
 
Andrew Ashworth, who retires after three and a half years as BioAmber’s CFO, had a long and distinguished career that previously included senior positions at Genencor/Danisco and VF Corporation. Andrew was instrumental in preparing BioAmber for its initial public offering, completing the IPO in 2013 and ensuring regulatory compliance since the listing. Andrew will continue in an advisory role to the company in the first half of 2015 to ensure a smooth transition.
 
“Andy has been a valued colleague who has extensive experience helped guide our IPO efforts. He will be missed and we wish him the best in his retirement. I am pleased to welcome Francois Laurin, a seasoned, dynamic CFO with extensive public company experience.  He is a great addition and will help lead BioAmber through our next stage of growth,” said JF Huc, CEO, BioAmber.